Delivery Order SPE2DB25D3005-SPE2DB25FQGXP
- Not listed
- This federal contract award is for the delivery of RIFAMPIN 300 MG CAPSULE 60S to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $3,963.40, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order on a Firm Fixed Price basis, with an Ultimate Completion Date of July 11, 2025. This contract is not designated as a Set-Aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of 4,567,279,694 units of RIFAMPIN 300 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The contract, valued at $4,791.36, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.31 firm fixed-price delivery order contract is for the supply of RIFAMPIN 300 MG CAPSULE 30S, a critical pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,621.59 firm fixed-price delivery order contract is for the provision of 4567253390 RIFAMPIN 300 MG CAPSULE 60S, with a performance period extending through February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $2,746.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The contract has an Ultimate Completion Date of July 19, 2024 and a Ceiling Value of $2,746.58. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $3,447.37 for the procurement of 4564640497 - RIFAMPIN 300 MG CAPSULE 60S. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RIFAMPIN 300 MG CAPSULE UD 100S, a prescription medication. The contract has a ceiling value of $23,112.78 and is a Firm Fixed Price Delivery Order with a performance period ending on May 23, 2025. The contract is not a set-aside award, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,187.50 firm-fixed-price contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication. The order has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The company also holds a significant...
- This federal contract award, valued at $1,200.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, to support military healthcare...
- This is a $3,733.98 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is to provide RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set-aside and was awarded on June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQGXPDelivery Order
This federal contract award is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, to the U.S. government. The contract, valued at $1,157.46, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 17, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/16/25 |